Early glycoxidation damage in brains from Down's syndrome

被引:98
作者
Odetti, P
Angelini, G
Dapino, D
Zaccheo, D
Garibaldi, S
Dagna-Bricarelli, F
Piombo, G
Perry, G
Smith, M
Traverso, N
Tabaton, M
机构
[1] Univ Genoa, DIMI, Dept Internal Med, I-16132 Genoa, Italy
[2] Natl Canc Inst, Adv Biotechnol Ctr, I-16132 Genoa, Italy
[3] Univ Genoa, Inst Human Anat, I-16132 Genoa, Italy
[4] Galliera Hosp, Ctr Human Genet, I-16128 Genoa, Italy
[5] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA
[6] Univ Genoa, Inst Gen Pathol, Genoa, Italy
[7] Univ Genoa, Dept Neurosci, Genoa, Italy
关键词
D O I
10.1006/bbrc.1998.8186
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In Down's syndrome, the presence of three copies of chromosome 21 is associated with premature aging and progressive mental retardation sharing the pathological features of Alzheimer disease, Early cortical dysgenesis and late neuronal degeneration are probably caused by an overproduction of amyloid beta-peptide, followed by an increased cellular oxidation. Interestingly, chromosome 21 codes for superoxide-dismutase and amyloid beta precursor resulting, in Down's syndrome, in an overflow of these gene products and metabolites. We studied Down's fetal brain cortex to evaluate the presence and amount of lipid and protein oxidation markers; moreover, we quantified two forms of glycation end products that are known to be involved in the process of cellular oxidation. All these parameters are significantly increased in Down's fetal brains in comparison to controls, providing the evidence that accelerated brain glycoxidation occurs very early in the life of Down's syndrome subjects. (C) 1998 Academic Press.
引用
收藏
页码:849 / 851
页数:3
相关论文
共 17 条
  • [11] Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome
    Teller, JK
    Russo, C
    DeBusk, LM
    Angelini, G
    Zaccheo, D
    DagnaBricarelli, F
    Scartezzini, P
    Bertolini, S
    Mann, DMA
    Tabaton, M
    Gambetti, P
    [J]. NATURE MEDICINE, 1996, 2 (01) : 93 - 95
  • [12] Role of the maillard reaction in diabetes mellitus and diseases of aging
    Thorpe, SR
    Baynes, JW
    [J]. DRUGS & AGING, 1996, 9 (02) : 69 - 77
  • [13] MODIFICATION OF HISTIDINE-RESIDUES IN PROTEINS BY REACTION WITH 4-HYDROXYNONENAL
    UCHIDA, K
    STADTMAN, ER
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) : 4544 - 4548
  • [14] WISNIEWSKI KE, 1986, NEUROBIOGY DOWNS SYN
  • [15] Yan SD, 1997, NATURE, V389, P689
  • [16] RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease
    Yan, SD
    Chen, X
    Fu, J
    Chen, M
    Zhu, HJ
    Roher, A
    Slattery, T
    Zhao, L
    Nagashima, M
    Morser, J
    Migheli, A
    Nawroth, P
    Stern, D
    Schmidt, AM
    [J]. NATURE, 1996, 382 (6593) : 685 - 691
  • [17] MEASUREMENT OF MALONDIALDEHYDE IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUOROMETRIC DETECTION
    YOUNG, IS
    TRIMBLE, ER
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 1991, 28 : 504 - 508